U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C14H18N2O
Molecular Weight 230.3055
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LUCIGENOL

SMILES

[H][C@]3(CC1=CNC2=CC=CC(O)=C12)CCCN3C

InChI

InChIKey=XYRKPZYRLSWABB-LLVKDONJSA-N
InChI=1S/C14H18N2O/c1-16-7-3-4-11(16)8-10-9-15-12-5-2-6-13(17)14(10)12/h2,5-6,9,11,15,17H,3-4,7-8H2,1H3/t11-/m1/s1

HIDE SMILES / InChI

Molecular Formula C14H18N2O
Molecular Weight 230.3055
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 10:25:21 GMT 2023
Edited
by admin
on Sat Dec 16 10:25:21 GMT 2023
Record UNII
46OU9HLZ35
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LUCIGENOL
Common Name English
4-HYDROXY-N-METHYL-(.ALPHA.,N-TRIMETHYLENE)TRYPTAMINE
Common Name English
4-HO-MPMI
Common Name English
1H-INDOL-4-OL, 3-(((2R)-1-METHYL-2-PYRROLIDINYL)METHYL)-
Systematic Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-4-HO-MPMI
Created by admin on Sat Dec 16 10:25:21 GMT 2023 , Edited by admin on Sat Dec 16 10:25:21 GMT 2023
Code System Code Type Description
CAS
250672-65-2
Created by admin on Sat Dec 16 10:25:21 GMT 2023 , Edited by admin on Sat Dec 16 10:25:21 GMT 2023
PRIMARY
PUBCHEM
10466404
Created by admin on Sat Dec 16 10:25:21 GMT 2023 , Edited by admin on Sat Dec 16 10:25:21 GMT 2023
PRIMARY
EPA CompTox
DTXSID80440389
Created by admin on Sat Dec 16 10:25:21 GMT 2023 , Edited by admin on Sat Dec 16 10:25:21 GMT 2023
PRIMARY
WIKIPEDIA
4-HO-MPMI
Created by admin on Sat Dec 16 10:25:21 GMT 2023 , Edited by admin on Sat Dec 16 10:25:21 GMT 2023
PRIMARY 4-HO-MPMI (also known as 4-Hydroxy-N-methyl-(α,N-trimethylene)tryptamine or lucigenol) is a tryptamine derivative that is a psychedelic drug. It was developed by the team led by David Nichols from Purdue University in the late 1990s. This compound produces hallucinogen-appropriate responding in animal tests with a similar potency to the amphetamine-derived psychedelic DOI, and has two enantiomers, with only the (R)-enantiomer being active.
FDA UNII
46OU9HLZ35
Created by admin on Sat Dec 16 10:25:21 GMT 2023 , Edited by admin on Sat Dec 16 10:25:21 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY